The company will deploy its advanced quantum computer here, making it the city-state’s first commercial one Read more at The ...

Motor imagery (MI) is the mental process of imagining a specific limb movement, such as raising a hand or walking, without physically performing it. These imagined movements generate distinct patterns ...

Researchers at Chiba University in Japan have developed a new artificial intelligence framework capable of decoding complex brain activity with significantly improved accuracy, marking an important ...

Motor imagery electroencephalography (EEG) signals depict changes in brain activity during imagined limb movements. Conventional methods, however, often fail to capture these spatiotemporal variations ...

Have you evaluated the performance of Guidewire Software's (GWRE) international operations for the quarter ending January 2026? Given the extensive global presence of this provider of software to the ...

Motor imagery (MI) is the mental process of imagining a specific limb movement, such as raising a hand or walking, without physically performing it ...

BrainWhisperer is Tether’s Brain-to-text project. Tether is earmarking resources to build technologies that push the borders of intracranial electrocortical decoding. The latest result is a variable ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

A Pune techie shared that Deepinder Goyal noticed him after users tagged him in Temple hiring discussions. | Trending ...

No one has had a Synchron brain-computer interface longer than Rodney Gorham. He’s still finding new ways to use it.

The experiment was conducted by researchers at Stanford University in the United States as part of a wider study involving patients with amyotrophic lateral sclerosis (ALS), a progressive neurodegener ...

China’s brain-computer interface industry is rapidly scaling from research to commercialization, driven by strong policy support, expanding clinical trials, and growing investor interest.